VE treatment attenuates allergic asthma by reducing levels of peroxynitrite, NO2−, IgE, eotaxin, IgE, TGF-β1, IL-4, IL-5, and IL-13 [96]. The gene discussed is IGHE; the disease is allergic asthma.